We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...
Global Phase 1 study of CLN-978 in systemic lupus erythematosus (SLE) cleared to initiate in U.S. and Australia; initial clinical data expected in Q4 2025 CLN-619 on-track for initial expansion...
CAMBRIDGE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted...
CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.18 | 9.61695191524 | 12.27 | 13.45 | 12.1 | 496881 | 12.67884164 | CS |
4 | -2.26 | -14.3857415659 | 15.71 | 17.5034 | 12.04 | 587953 | 14.61070288 | CS |
12 | -4.39 | -24.6076233184 | 17.84 | 18.6199 | 12.04 | 537435 | 16.16657493 | CS |
26 | -8.87 | -39.7401433692 | 22.32 | 24.76 | 12.04 | 641601 | 17.63776891 | CS |
52 | 4.81 | 55.6712962963 | 8.64 | 30.1886 | 7.64 | 605023 | 18.36425422 | CS |
156 | -4.77 | -26.1800219539 | 18.22 | 30.1886 | 7.3 | 373249 | 15.28006233 | CS |
260 | -28.55 | -67.9761904762 | 42 | 59.85 | 7.3 | 345320 | 18.0457846 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions